PE20030311A1 - Composicion oftalmica que comprende ascomicina - Google Patents
Composicion oftalmica que comprende ascomicinaInfo
- Publication number
- PE20030311A1 PE20030311A1 PE2002000808A PE2002000808A PE20030311A1 PE 20030311 A1 PE20030311 A1 PE 20030311A1 PE 2002000808 A PE2002000808 A PE 2002000808A PE 2002000808 A PE2002000808 A PE 2002000808A PE 20030311 A1 PE20030311 A1 PE 20030311A1
- Authority
- PE
- Peru
- Prior art keywords
- copolymer
- ascomycin
- composition including
- ophthalmic composition
- eye
- Prior art date
Links
- ZDQSOHOQTUFQEM-PKUCKEGBSA-N ascomycin Chemical compound C/C([C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H]([C@H](C[C@H]2C)OC)[C@@H](OC)C[C@@H](C)C\C(C)=C/[C@H](C(C[C@H](O)[C@H]1C)=O)CC)=C\[C@@H]1CC[C@@H](O)[C@H](OC)C1 ZDQSOHOQTUFQEM-PKUCKEGBSA-N 0.000 title 1
- ZDQSOHOQTUFQEM-XCXYXIJFSA-N ascomycin Natural products CC[C@H]1C=C(C)C[C@@H](C)C[C@@H](OC)[C@H]2O[C@@](O)([C@@H](C)C[C@H]2OC)C(=O)C(=O)N3CCCC[C@@H]3C(=O)O[C@H]([C@H](C)[C@@H](O)CC1=O)C(=C[C@@H]4CC[C@@H](O)[C@H](C4)OC)C ZDQSOHOQTUFQEM-XCXYXIJFSA-N 0.000 title 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 abstract 2
- 229920001577 copolymer Polymers 0.000 abstract 2
- 206010027654 Allergic conditions Diseases 0.000 abstract 1
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 208000003556 Dry Eye Syndromes Diseases 0.000 abstract 1
- 206010013774 Dry eye Diseases 0.000 abstract 1
- 206010046851 Uveitis Diseases 0.000 abstract 1
- 229920001400 block copolymer Polymers 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 206010023332 keratitis Diseases 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Abstract
QUE COMPRENDE: 1)33-EPI-CLORO-33-DESOXI-ASCOMICINA.; 2)AL MENOS UN POLIMERO SELECCIONADO DE: i)UN COPOLIMERO O COPOLIMERO DE BLOQUE DE POLIOXIETILENO-POLIOXIPROPILENO; Y, ii)UN HOMO- o COPOLIMERO RETICULADO DE ACIDO ACRILICO; 3)UN AGENTE MEJORADOR DE TONICIDAD; UN REGULADOR DE PH, UN CONSERVADOR Y UN VEHICULO OFTALMICO. TIENE APLICACION EN EL TRATAMIENTO DE CONDICIONES INMUNO-MEDIADAS DEL OJO, TALES COMO ENFERMEDADES AUTOINMUNES, COMO OJO RESECO, UVEITIS, QUERATOPLASTIA O QUERATITIS CRONICA, CONDICIONES ALERGICAS COMO CONJUNTIVITIS VERNAL, CONDICIONES INFLAMATORIAS O TRANSPLANTE DE CORNEA
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31444801P | 2001-08-23 | 2001-08-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20030311A1 true PE20030311A1 (es) | 2003-05-08 |
Family
ID=23219986
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2002000808A PE20030311A1 (es) | 2001-08-23 | 2002-08-22 | Composicion oftalmica que comprende ascomicina |
Country Status (28)
| Country | Link |
|---|---|
| US (2) | US20030050255A1 (es) |
| EP (1) | EP1420787B8 (es) |
| JP (1) | JP2005501105A (es) |
| KR (2) | KR20100089108A (es) |
| CN (1) | CN100366251C (es) |
| AR (1) | AR035293A1 (es) |
| AT (1) | ATE452638T1 (es) |
| AU (1) | AU2002331172B2 (es) |
| BR (1) | BR0211972A (es) |
| CA (1) | CA2457034C (es) |
| CO (1) | CO5560568A2 (es) |
| DE (1) | DE60234840D1 (es) |
| EC (1) | ECSP044981A (es) |
| ES (1) | ES2337130T3 (es) |
| HK (1) | HK1065961A1 (es) |
| HU (1) | HUP0402396A3 (es) |
| IL (1) | IL160374A0 (es) |
| MX (1) | MXPA04001646A (es) |
| MY (1) | MY157377A (es) |
| NO (1) | NO20040775L (es) |
| NZ (1) | NZ531224A (es) |
| PE (1) | PE20030311A1 (es) |
| PL (1) | PL208685B1 (es) |
| PT (1) | PT1420787E (es) |
| RU (1) | RU2313344C2 (es) |
| TW (1) | TWI324925B (es) |
| WO (1) | WO2003017990A2 (es) |
| ZA (1) | ZA200400772B (es) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7354574B2 (en) | 2002-11-07 | 2008-04-08 | Advanced Ocular Systems Limited | Treatment of ocular disease |
| US7083802B2 (en) * | 2003-07-31 | 2006-08-01 | Advanced Ocular Systems Limited | Treatment of ocular disease |
| US7585517B2 (en) | 2003-09-18 | 2009-09-08 | Macusight, Inc. | Transscleral delivery |
| US7083803B2 (en) | 2003-09-19 | 2006-08-01 | Advanced Ocular Systems Limited | Ocular solutions |
| US7087237B2 (en) | 2003-09-19 | 2006-08-08 | Advanced Ocular Systems Limited | Ocular solutions |
| SI1848431T1 (sl) | 2005-02-09 | 2016-05-31 | Santen Pharmaceutical Co., Ltd. | Tekoče formulacije za zdravljenje bolezni ali stanj |
| CA2615990A1 (en) | 2005-07-18 | 2007-01-25 | Minu, L.L.C. | Enhanced ocular neuroprotection/neurostimulation |
| WO2007092620A2 (en) | 2006-02-09 | 2007-08-16 | Macusight, Inc. | Stable formulations, and methods of their preparation and use |
| DK2001466T3 (en) | 2006-03-23 | 2016-02-29 | Santen Pharmaceutical Co Ltd | LOW-DOSAGE RAPAMYCINE FOR TREATMENT OF VASCULAR PERMEABILITY-RELATED DISEASES |
| RU2445098C2 (ru) * | 2007-07-11 | 2012-03-20 | Пфайзер Инк. | Фармацевтические композиции и способы лечения сухих кератитов |
| MX2010011545A (es) | 2008-04-21 | 2011-04-11 | Otonomy Inc | Formulaciones para tratar enfermedades y afecciones del oido. |
| US11969501B2 (en) | 2008-04-21 | 2024-04-30 | Dompé Farmaceutici S.P.A. | Auris formulations for treating otic diseases and conditions |
| RU2469726C2 (ru) | 2008-05-14 | 2012-12-20 | Отономи, Инк. | Композиции с контролируемым высвобождением на основе кортикостероидов для лечения ушных болезней |
| US8648119B2 (en) | 2008-05-23 | 2014-02-11 | Otonomy, Inc. | Controlled release immunomodulator compositions and methods for the treatment of otic disorders |
| US8846770B2 (en) | 2008-06-18 | 2014-09-30 | Otonomy, Inc. | Controlled release aural pressure modulator compositions and methods for the treatment of OTIC disorders |
| US8349353B2 (en) | 2008-06-27 | 2013-01-08 | Otonomy, Inc. | Controlled release cytotoxic agent compositions and methods for the treatment of otic disorders |
| WO2010011466A2 (en) | 2008-06-27 | 2010-01-28 | Otonomy, Inc. | Controlled-release cns modulating compositions and methods for the treatment of otic disorders |
| US8496957B2 (en) | 2008-07-21 | 2013-07-30 | Otonomy, Inc | Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders |
| US8318817B2 (en) | 2008-07-21 | 2012-11-27 | Otonomy, Inc. | Controlled release antimicrobial compositions and methods for the treatment of otic disorders |
| US8399018B2 (en) | 2008-07-21 | 2013-03-19 | Otonomy, Inc. | Controlled release ion channel modulator compositions and methods for the treatment of otic disorders |
| US10092580B2 (en) | 2008-07-21 | 2018-10-09 | Otonomy, Inc. | Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disorders |
| WO2010048095A2 (en) | 2008-10-22 | 2010-04-29 | House Ear Institute | Treatment and/or prevention of inner ear conditions by modulation of a metabotropic glutamate receptor |
| CN105682742A (zh) | 2013-08-27 | 2016-06-15 | 奥德纳米有限公司 | 小儿耳部病症的治疗 |
| KR102766991B1 (ko) | 2015-11-16 | 2025-02-13 | 메딘셀 에스.에이. | 활액 조직에 약제학적으로 활성인 유효성분을 모셀라이징 및/또는 표적화하는 방법 |
| US11040004B2 (en) | 2016-09-16 | 2021-06-22 | Otonomy, Inc. | Otic gel formulations for treating otitis externa |
| JP2020094036A (ja) * | 2018-11-30 | 2020-06-18 | ロート製薬株式会社 | 光線による障害からの細胞保護用眼科組成物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0551626A1 (en) * | 1991-12-19 | 1993-07-21 | LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d. | Thermoreversible gel as a liquid pharmaceutical carrier for a galenic formulation |
| JPH06345646A (ja) * | 1993-06-08 | 1994-12-20 | Fujisawa Pharmaceut Co Ltd | ローション剤 |
| DE19581804T1 (de) * | 1994-10-26 | 1998-01-22 | Ciba Geigy Ag | Pharmazeutische Zusammensetzungen |
| JP4221762B2 (ja) * | 1997-04-11 | 2009-02-12 | アステラス製薬株式会社 | 医薬組成物 |
| CZ287497B6 (cs) * | 1997-12-30 | 2000-12-13 | Galena, A. S. | Topické oční přípravky s imunosupresivními látkami |
-
2002
- 2002-08-21 TW TW091118911A patent/TWI324925B/zh not_active IP Right Cessation
- 2002-08-21 AR ARP020103137A patent/AR035293A1/es unknown
- 2002-08-22 PE PE2002000808A patent/PE20030311A1/es not_active Application Discontinuation
- 2002-08-22 ES ES02767419T patent/ES2337130T3/es not_active Expired - Lifetime
- 2002-08-22 AU AU2002331172A patent/AU2002331172B2/en not_active Ceased
- 2002-08-22 MX MXPA04001646A patent/MXPA04001646A/es active IP Right Grant
- 2002-08-22 JP JP2003522510A patent/JP2005501105A/ja active Pending
- 2002-08-22 HU HU0402396A patent/HUP0402396A3/hu unknown
- 2002-08-22 NZ NZ531224A patent/NZ531224A/en not_active IP Right Cessation
- 2002-08-22 CN CNB028164466A patent/CN100366251C/zh not_active Expired - Fee Related
- 2002-08-22 RU RU2004108463/15A patent/RU2313344C2/ru not_active IP Right Cessation
- 2002-08-22 KR KR1020107014068A patent/KR20100089108A/ko not_active Abandoned
- 2002-08-22 PL PL367459A patent/PL208685B1/pl not_active IP Right Cessation
- 2002-08-22 PT PT02767419T patent/PT1420787E/pt unknown
- 2002-08-22 EP EP02767419A patent/EP1420787B8/en not_active Expired - Lifetime
- 2002-08-22 AT AT02767419T patent/ATE452638T1/de active
- 2002-08-22 BR BR0211972-2A patent/BR0211972A/pt active Search and Examination
- 2002-08-22 KR KR10-2004-7002458A patent/KR20040030157A/ko not_active Ceased
- 2002-08-22 DE DE60234840T patent/DE60234840D1/de not_active Expired - Lifetime
- 2002-08-22 IL IL16037402A patent/IL160374A0/xx unknown
- 2002-08-22 CA CA2457034A patent/CA2457034C/en not_active Expired - Fee Related
- 2002-08-22 WO PCT/EP2002/009408 patent/WO2003017990A2/en active Application Filing
- 2002-08-22 MY MYPI20023102A patent/MY157377A/en unknown
- 2002-08-23 US US10/227,086 patent/US20030050255A1/en not_active Abandoned
-
2004
- 2004-01-30 ZA ZA200400772A patent/ZA200400772B/en unknown
- 2004-02-17 NO NO20040775A patent/NO20040775L/no not_active Application Discontinuation
- 2004-02-18 EC EC2004004981A patent/ECSP044981A/es unknown
- 2004-02-18 CO CO04013810A patent/CO5560568A2/es not_active Application Discontinuation
- 2004-11-15 HK HK04109014.9A patent/HK1065961A1/xx not_active IP Right Cessation
-
2010
- 2010-11-30 US US12/955,950 patent/US20110071186A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20030311A1 (es) | Composicion oftalmica que comprende ascomicina | |
| BR0314266A (pt) | Dispositivos e métodos para a melhora de visão | |
| WO2007104541A3 (en) | Compositions and methods using serine protease inhibiting peptides for treating ophthalmic disorders | |
| BRPI0414062A (pt) | uso de ciclosporinas midificadas para o tratamento de distúrbios por hcv | |
| BRPI0410784A (pt) | métodos e composições para tratar distúrbios oculares | |
| DE69906030D1 (de) | Linsen zur korrektur von kurzsichtigkeit | |
| ATE273009T1 (de) | Substituierte tetrahydrofuran-analoge von prostaglandinen als augendrucksenkende mittel | |
| ATE433850T1 (de) | Ophtalmische linsen und zusammensetzungen und verfahren zu deren herstellung | |
| BR0213738A (pt) | proteìnas morfogênicas ósseas (bmp), receptores de bmp e proteìnas de ligação de bmp e seu uso no diagnóstico e no tratamento de glaucoma | |
| ATE196507T1 (de) | Verfahren zur herstellung von viralen vektoren von mindestens 20kb durch intermolekulare homologe rekombination in einer prokaryotischen zelle | |
| BRPI0512949A (pt) | soluções para lentes oftálmicas contendo pelo menos um componente contendo silicone | |
| EP0932613A4 (en) | EXPRESSION BLOCKING OF VIRULENT FACTORS IN S. AUREUS | |
| ATE413179T1 (de) | Therapeutische verwendungen von steroiden bei blutzellmangelzustaenden | |
| CA2254682A1 (en) | Method of treating eye infections with azithromycin | |
| JPS5977411A (ja) | 酸素透過性ハ−ドコンタクトレンズ | |
| ES2134268T3 (es) | Anillo corneo intraestromal corrector del astigmatismo. | |
| DE60044247D1 (de) | Humane cd80-mutante und zusammensetzungen und methoden zu deren herstellung und verwendung | |
| BR0110786A (pt) | Composição aperfeiçoada de borracha | |
| ES2126806T3 (es) | Fibras conjugadas con alta capacidad de rizado y telas no tejidas fabricadas a partir de ellas. | |
| HK1063601A1 (en) | Compositions and methods for treating hyperimmune response in the eye | |
| BR9914848A (pt) | Composição e processo para o tratamento de distúrbios da retina externa | |
| DE60120127D1 (de) | Injizierbare mikrokügelchen für den gewebeaufbau | |
| HK1012650A1 (en) | Method for reducing tackiiness of soft acrylic polymers | |
| BR0016415A (pt) | Inibidores de adenosina cinase para o tratamento de dano retinal e de nervo ótico | |
| EP1160275A4 (en) | CROSSLINKABLE ELASTOMER COMPOSITION, SEALING MATERIAL MADE FROM THIS COMPOSITION AND FILLER FOR USE IN IT |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |